Versor Investments LP Purchases New Position in HealthEquity, Inc. (NASDAQ:HQY)

Versor Investments LP purchased a new stake in shares of HealthEquity, Inc. (NASDAQ:HQY) in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The firm purchased 9,100 shares of the company’s stock, valued at approximately $873,000.

Other institutional investors also recently bought and sold shares of the company. Arcadia Investment Management Corp MI purchased a new stake in shares of HealthEquity in the fourth quarter valued at approximately $26,000. Proficio Capital Partners LLC purchased a new stake in shares of HealthEquity in the fourth quarter valued at approximately $39,000. UMB Bank n.a. increased its position in shares of HealthEquity by 65.6% in the fourth quarter. UMB Bank n.a. now owns 414 shares of the company’s stock valued at $40,000 after buying an additional 164 shares in the last quarter. First Horizon Advisors Inc. increased its position in shares of HealthEquity by 50.7% in the fourth quarter. First Horizon Advisors Inc. now owns 1,115 shares of the company’s stock valued at $107,000 after buying an additional 375 shares in the last quarter. Finally, Quarry LP increased its position in shares of HealthEquity by 418.8% in the third quarter. Quarry LP now owns 1,349 shares of the company’s stock valued at $110,000 after buying an additional 1,089 shares in the last quarter. 99.55% of the stock is currently owned by hedge funds and other institutional investors.

HealthEquity Stock Performance

NASDAQ HQY opened at $107.05 on Friday. The stock’s fifty day moving average is $104.84 and its two-hundred day moving average is $93.08. The firm has a market capitalization of $9.28 billion, a P/E ratio of 98.21, a price-to-earnings-growth ratio of 1.60 and a beta of 0.55. The company has a debt-to-equity ratio of 0.51, a quick ratio of 3.20 and a current ratio of 3.20. HealthEquity, Inc. has a fifty-two week low of $65.01 and a fifty-two week high of $115.59.

HealthEquity (NASDAQ:HQY) last announced its quarterly earnings results on Monday, December 9th. The company reported $0.59 EPS for the quarter, missing the consensus estimate of $0.71 by ($0.12). HealthEquity had a net margin of 8.41% and a return on equity of 9.70%. During the same period last year, the business posted $0.40 earnings per share. On average, research analysts anticipate that HealthEquity, Inc. will post 2.32 earnings per share for the current year.

Analysts Set New Price Targets

HQY has been the subject of a number of recent analyst reports. Mizuho initiated coverage on HealthEquity in a research report on Wednesday, December 4th. They issued an “outperform” rating and a $126.00 price objective for the company. Raymond James boosted their price objective on HealthEquity from $105.00 to $120.00 and gave the company an “outperform” rating in a research report on Tuesday. The Goldman Sachs Group began coverage on HealthEquity in a research note on Friday, November 15th. They issued a “neutral” rating and a $108.00 price target on the stock. Barrington Research lifted their price target on HealthEquity from $105.00 to $120.00 and gave the stock an “outperform” rating in a research note on Monday, December 2nd. Finally, Bank of America lifted their price target on HealthEquity from $100.00 to $120.00 and gave the stock a “buy” rating in a research note on Wednesday, November 13th. One analyst has rated the stock with a hold rating and twelve have given a buy rating to the stock. Based on data from MarketBeat.com, HealthEquity presently has an average rating of “Moderate Buy” and a consensus target price of $113.54.

Insider Activity

In other news, Director Stuart B. Parker sold 25,000 shares of the company’s stock in a transaction on Thursday, December 12th. The stock was sold at an average price of $96.72, for a total value of $2,418,000.00. Following the transaction, the director now owns 19,061 shares of the company’s stock, valued at $1,843,579.92. This represents a 56.74 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, Director Robert W. Selander sold 8,250 shares of the business’s stock in a transaction on Monday, December 9th. The shares were sold at an average price of $101.56, for a total value of $837,870.00. Following the completion of the sale, the director now owns 66,469 shares in the company, valued at $6,750,591.64. This represents a 11.04 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 39,000 shares of company stock valued at $3,895,788 in the last quarter. Insiders own 2.20% of the company’s stock.

About HealthEquity

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.